1. Epigenetic link between Agent Orange exposure and type 2 diabetes in Korean veterans
- Author
-
Sujin Seo, Ye An Kim, Young Lee, Young Jin Kim, Bong-Jo Kim, Jae Hoon An, Heejin Jin, Ah Ra Do, Kyungtaek Park, Sungho Won, and Je Hyun Seo
- Subjects
Agent Orange ,ageing ,epigenome-wide association study ,microvascular complications ,Mendelian randomization ,type 2 diabetes ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Conflicting findings have been reported regarding the association between Agent Orange (AO) exposure and type 2 diabetes. This study aimed to examine whether AO exposure is associated with the development of type 2 diabetes and to verify the causal relationship between AO exposure and type 2 diabetes by combining DNA methylation with DNA genotype analyses. An epigenome-wide association study and DNA genotype analyses of the blood of AO-exposed and AO-unexposed individuals with type 2 diabetes and that of healthy controls were performed. Methylation quantitative trait locus and Mendelian randomisation analyses were performed to evaluate the causal effect of AO-exposure-identified CpGs on type 2 diabetes. AO-exposed individuals with type 2 diabetes were associated with six hypermethylated CpG sites (cg20075319, cg21757266, cg05203217, cg20102280, cg26081717, and cg21878650) and one hypo-methylated CpG site (cg07553761). Methylation quantitative trait locus analysis showed the methylation levels of some CpG sites (cg20075319, cg20102280, and cg26081717) to be significantly different. Mendelian randomisation analysis showed that CpG sites that were differentially methylated in AO-exposed individuals were causally associated with type 2 diabetes; the reverse causal effect was not significant. These findings reflect the need for further epigenetic studies on the causal relationship between AO exposure and type 2 diabetes.
- Published
- 2024
- Full Text
- View/download PDF